David Kirn, See Remarks at 4D Molecular Therapeutics, Inc. (FDMT), sold 58,333 shares at $12.92 ($754K) on 2026-10-05, disclosed to the SEC on 2026-10-07.
Scheduled sale ($754k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.92 | 58,061 | $750K | 99.5% |
| 2 | $13.61 | 272 | $4K | 0.5% |
| Total | $12.92 avg | 58,333 | $754K | 100% |
| Filing → |
| FDMT | SELL | 2026-08-05 | $275K | — | Filing → |
| FDMT | SELL | 2026-08-04 | $125K | — | Filing → |
| FDMT | SELL | 2026-07-14 | $737K | — | Filing → |